A detailed history of Flagstone Financial Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Flagstone Financial Management holds 248 shares of LLY stock, worth $190,404. This represents 0.07% of its overall portfolio holdings.

Number of Shares
248
Holding current value
$190,404
% of portfolio
0.07%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$772.14 - $960.02 $191,490 - $238,084
248 New
248 $220 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Flagstone Financial Management Portfolio

Follow Flagstone Financial Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flagstone Financial Management, based on Form 13F filings with the SEC.

News

Stay updated on Flagstone Financial Management with notifications on news.